PATENT CLAIM ANALYSIS

Application Number: 15754842
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "045000"]

Abstract:
A problem to be solved by the present invention is to provide a substance having an effect of increasing intracellular ATP and, particularly, a potent ATP enhancer far surpassing the increasing effect of inosine or febuxostat alone. A human or animal intracellular ATP enhancer comprising a combination of A) and B): A) a xanthine oxidase/xanthine dehydrogenase inhibitor or a pharmaceutically acceptable salt thereof; and B) any one or more compounds selected from inosine, inosinic acid, hypoxanthine, and pharmaceutically acceptable salts thereof.

Claim (Index 5):
A pharmaceutical product that is a combination drug or a kit formulation comprising a combination of A) and B):\n A) a xanthine oxidase/xanthine dehydrogenase inhibitor or a pharmaceutically acceptable salt thereof; and B) any one or more compounds selected from inosine, inosinic acid, hypoxanthine, and pharmaceutically acceptable salts thereof.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 88.0
- Lexical Diversity: 1.62069
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14355480', '13174522', '13174594', '13174568', '15358586']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7488775436609507
- 35 USC 102 Novelty (BERT): 0.5310223964280247
- Combined Prediction Score: 0.7270920289376581
- Mean Citation Score: 315.230968
- Max Citation Score: 333.34375
- Similarity Product: 223.75068899802864

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test